Venous Symposium’s Post

📢 𝐍𝐞𝐰 #𝐏𝐚𝐩𝐞𝐫𝐀𝐥𝐞𝐫𝐭: Investigating the Role of GGT/HDL-C Ratio in Metabolic Syndrome Resolution after Sleeve Gastrectomy I'm thrilled to share our latest research published in Diabetes & Vascular Disease Research, which delves into the association between the GGT/HDL-C ratio and metabolic syndrome (MetS) resolution post-sleeve gastrectomy (SG) in adults. 𝐊𝐞𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬: ➡ Approximately 84% of patients achieved MetS resolution within 6 months post-SG. ➡ Lower GGT/HDL-C ratio pre-surgery was associated with a higher likelihood of MetS resolution post-surgery, independent of the criteria used (IDF or ALAD) ➡ The study underscores the importance of preoperative assessment markers in tailoring surgery and postoperative plans for patients with MetS. Our findings contribute to the understanding of metabolic outcomes following bariatric surgery, particularly in the context of the Latin American population. By identifying a potential biomarker for MetS resolution, our research opens avenues for personalized interventions and improved patient care. You can access the full paper here: https://lnkd.in/e7ui39xw #MetabolicSyndrome #SleeveGastrectomy #BariatricSurgery #GGT #HDL #Healthcare #Research #LatinPopulation #OBEMET

[18F]NaF PET and Heart Valve Disease Progression Aortic stenosis (a narrowing of the heart's aortic valve) gets worse over time due to calcification (buildup of calcium in the valve). Clinicians need a way to detect and predict this early before it becomes serious. Researchers studied 30 patients with aortic stenosis using advanced PET-CT scans. They tested two tracers: [18F]NaF to highlight calcium buildup. [18F]FDG to detect inflammation (body's response to damage). They compared scan results with actual valve tissue removed during surgery and tracked calcium buildup in some patients after one year. [18F]NaF scans clearly showed where calcium was actively building up and matched tissue/biopsy test results. It also accurately predicted how much the valve would worsen over time. [18F]FDG didn’t show a strong link to inflammation or disease progression. Key Takehome: [18F]NaF scans can spot early calcification and predict aortic stenosis progression, helping doctors manage and treat the disease sooner. Keywords: #HeartHealth #MedicalResearch #AorticStenosis #EarlyDetection #18FNaF #nucmed #molrad #nuclearmedicine #nuclearradiology #molecularimaging #petct #petmri #precisionmedicine #precisionimaging #BoneHealth #JointCare #HealthyBones #Osteoarthritis #BoneResearch #JointHealth #ImagingInnovation #StrongBones #BoneWellness #CartilageCare #BoneImaging #BoneStrength #BoneRemodeling #EarlyDetection #ArthritisAwareness Dweck MR, Jenkins WS, Vesey AT, Pringle MA, Chin CW, Malley TS, Cowie WJ, Tsampasian V, Richardson H, Fletcher A, Wallace WA, Pessotto R, van Beek EJ, Boon NA, Rudd JH, Newby DE. 18F-sodium fluoride uptake is a marker of active calcification and disease progression in patients with aortic stenosis. Circ Cardiovasc Imaging. 2014 Mar;7(2):371-8. doi: 10.1161/CIRCIMAGING.113.001508. Epub 2014 Feb 7. PMID: 24508669.

This study investigates the impact of using ECHELON ENDOPATH® Staple Line Reinforcement in functional end-to-end anastomosis (FEEA) to reduce anastomotic leakage (AL). Results indicate a significant reduction in AL rates in small intestine-colon anastomosis, highlighting the potential benefits of staple line reinforcement. Read more: https://bit.ly/3U0DQQf #CaseReport #Surgery #AnastomoticLeakage #StapleLineReinforcement #ClinicalResearch #FEEA #MedicalScience #SurgicalTechniques #HealthcareInnovation #PatientSafety #MedicalDevices #GastrointestinalSurgery #Ethicon #SurgicalOutcomes #HealthcareResearch #SurgicalCare #MedicalEducation #ClinicalOutcomes #Surgeons #ResearchStudy #InnovativeMedicine #Cureus #SurgicalInnovation #PatientCare #MedicalTechnology

This study investigates the impact of using ECHELON ENDOPATH® Staple Line Reinforcement in functional end-to-end anastomosis (FEEA) to reduce anastomotic leakage (AL). Results indicate a significant reduction in AL rates in small intestine-colon anastomosis, highlighting the potential benefits of staple line reinforcement. Read more: https://bit.ly/3U0DQQf #CaseReport #Surgery #AnastomoticLeakage #StapleLineReinforcement #ClinicalResearch #FEEA #MedicalScience #SurgicalTechniques #HealthcareInnovation #PatientSafety #MedicalDevices #GastrointestinalSurgery #Ethicon #SurgicalOutcomes #HealthcareResearch #SurgicalCare #MedicalEducation #ClinicalOutcomes #Surgeons #ResearchStudy #InnovativeMedicine #Cureus #SurgicalInnovation #PatientCare #MedicalTechnology

Thrombosis : Thrombosis, a condition characterized by the formation of blood clots within blood vessels, is a significant medical concern due to its potential to cause serious health complications. These clots, known as thrombi, can obstruct blood flow, leading to tissue damage, organ dysfunction, and even death if not promptly treated. One of the key factors contributing to thrombosis is the imbalance in the coagulation system, which involves a complex interplay of various factors such as platelets, clotting factors, and endothelial cells. When this balance is disrupted, either by genetic predisposition, underlying health conditions, or external factors like prolonged immobility or surgery, it can trigger the formation of abnormal blood clots. There are different types of thrombosis depending on the location of the clot. Venous thrombosis occurs in the veins and can manifest as deep vein thrombosis (DVT) in the legs or pulmonary embolism (PE) when a clot travels to the lungs. Arterial thrombosis, on the other hand, affects the arteries and can lead to conditions like myocardial infarction (heart attack) or stroke. #snsininstitutions #snsdesignthinkers #designthinking

🚨 Managing Glaucoma? Don’t Forget the Ocular Surface! 🚨 In this must-watch video, Justin Schweitzer, OD, FAAO emphasizes that while preventing #blindness from #glaucoma is crucial, we must also prioritize #ocularsurface health. 🌟 Many patients care more about how their eyes feel and look daily than a small visual field defect. 💬 We need to redefine "controlled glaucoma" to include not just target pressure and stable visual fields, but also the patient’s quality of life. 👁️✨ Key insights: Medications & Dry Eye: Studies show a 4x increase in #DryEyeDisease in patients on three glaucoma meds compared to one. Stacking medications can harm the ocular surface and accelerate disease progression. 💧💊 Solutions to Consider: Preservative-free formulations are gentler on the ocular surface. Selective laser trabeculoplasty (SLT) can reduce medication burden. Glaucoma drug delivery systems like Durysta and iDose eliminate the need for daily drops. Minimally Invasive Glaucoma Surgery (MIGS) decreases reliance on medications. 🔬 Remember, controlled glaucoma isn’t just about numbers—it’s about ensuring your patients maintain a good quality of life! 🩺 #Ophthalmology #Optometry #GlaucomaTreatment #EyeCare #SLT #MIGS Dr. Schweitzer has financial disclosures with Alcon AbbVie Bausch + Lomb , Sight Sciences Glaukos Corporation Dompé Ocular Therapeutix, Inc. References: Fechner et al., "Incidence of Dry Eye Disease in Glaucoma Patients," Journal of Glaucoma, 2010. Progression Study, "Impact of Side Effects on Visual Field Progression," Ophthalmic Research, 2004.

Advancing endoscopic evaluation of colorectal neoplasia through meticulous analysis. NICE classification elucidated: Type 1: Unremarkable mucosa Type 2: Adenomatous lesions Type 3: Malignant neoplasms Critical assessment parameters: Mucosal morphology Kudo pit pattern classification Sano vascular pattern grading Imperative for determining optimal therapeutic approach: endoscopic resection versus surgical intervention.

How can the medical community be good stewards of antibiotic technology while reducing surgical site infections? Read more in this fantastic editorial! #gutmicrobiome

Why do surgical site infections (SSIs) still happen, despite decades of effort and huge investments in prevention? John Alverdy, MD, a world-renowned expert on SSIs, has spent his career seeking answers. In a recent JAMA Surgery article, he dives into the current standard of care and proposes new strategies to tackle drug-resistant SSIs—highlighting the often-overlooked role of the gut microbiome in their origin. At 32 Biosciences, we're taking this research further with a groundbreaking, non-antibiotic anti-infective drug developed by Dr. Alverdy. Designed to collaborate with the gut microbiome, this drug aims to reduce SSI incidence while avoiding the spread of antimicrobial resistance. A smarter, safer future for surgical outcomes could be just around the corner. #SSI #Microbiome #AntimicrobialResistance #SurgicalInnovation #HealthTech #GutHealth

Laparoscopic anatomical right hepatectomy demonstrates favorable surgical outcomes. 🪡 read our summary 👉 https://lnkd.in/dAeu_4GF. by Liu C, Liu H (...) Yang H et 6 al. in Clin Res Hepatol Gastroenterol